Group 1 - Several securities firms, including CITIC Securities and Guosen Securities, have quickly launched trading permissions for the new Sci-Tech Growth Board, indicating high market interest in this new segment [1] - Investors need to meet a threshold of 500,000 yuan in assets and have two years of investment experience to participate, which helps filter qualified investors and manage risks [1] - The introduction of the Sci-Tech Growth Board enhances the multi-tiered capital market structure, providing financing channels for tech innovation companies, which is expected to boost overall market vitality and innovation momentum in the long term [1] Group 2 - On July 29, Founder Securities announced that its major shareholder, China Cinda Asset Management, did not execute its planned share reduction, which is seen as a positive signal for the company's long-term value [2] - The unchanged shareholding of China Cinda, which holds 593 million shares (7.2% of total shares), may help stabilize market sentiment and alleviate investor concerns about share dilution [2] - This situation is likely to support the brokerage sector and enhance confidence in financial stocks, contributing to market stability [2] Group 3 - In July, over 900 billion yuan worth of new funds were issued, indicating a recovery in market confidence [3] - The increase in stock and bond fund shares, driven by the equity market and innovative products like the Sci-Tech Bond ETF, reflects a growing risk appetite among investors [3] - The decline in mixed fund shares suggests a preference for clearer directional investments, which may lead to increased activity in related sectors and improved market liquidity [3] Group 4 - Seven ETFs have achieved "doubling" performance this year, with the top performer, Huatai-PB Hang Seng Innovation Drug ETF, showing a 107.67% return [4] - The strong performance of Hong Kong innovation drug ETFs highlights the robust market interest in the innovative drug sector, potentially attracting more capital into the healthcare segment [4] - Continued advancements in innovative drug research and supportive policies are key drivers for the pharmaceutical industry, with high-performing ETFs likely to enhance investor risk appetite [4]

Report Industry Investment Rating No relevant content provided. Core Viewpoints - In the week from July 21 - 25, 2025, the bond market adjusted. The net value of benchmark market - making credit bond ETFs and science - innovation bond ETFs declined significantly, and the overall net subscription of science - innovation bonds was 5.56 billion yuan. Institutions may have redeemed ETF shares to cope with liquidity shocks [4]. - After the adjustment, some science - innovation bonds have fallen to a point where they offer value. For allocation portfolios, some exchange - traded science - innovation bonds with a remaining term of 4 - 5 years are worth considering; for trading portfolios, short - term index component science - innovation bonds are more attractive [4]. - The science - innovation bond ETF is expected to expand further. After the adjustment, index component science - innovation bonds with a widening relative spread have certain value, and investors can participate at the current adjusted points and wait for the spread to recover [46]. Summary by Directory I. First Batch of Science - Innovation Bond ETFs Expanded Rapidly in One Week after Listing - On July 17, 2025, 10 science - innovation bond ETFs were listed. By July 25, the total scale exceeded 100 billion yuan, with a growth rate of over 250% [15]. - The 10 products were all raised on July 7, 2025, and the total raised scale was about 29 billion yuan, indicating strong market demand [15]. - There are differences in product elements such as redemption methods, product durations, and component bond capacities among these 10 science - innovation bond ETFs [20]. II. Index Component Bonds of Science - Innovation Bond ETFs Led the Decline in this Adjustment - In terms of net value fluctuations, the net value of benchmark market - making credit bond ETFs and science - innovation bond ETFs declined by about 0.3% in a week [29]. - In terms of subscription and redemption data, the overall net subscription of science - innovation bonds was 5.56 billion yuan, while short - term financing ETFs and benchmark market - making credit bond ETFs with good liquidity were more affected by redemptions, suggesting that institutions may have redeemed shares for liquidity reasons [4]. - In terms of the performance of underlying component bonds, science - innovation bond index component bonds had a faster adjustment speed and a larger adjustment range. Exchange - traded non - science - innovation index component science - innovation bonds and inter - bank science - innovation bonds were relatively more resilient [35]. III. Which Science - Innovation Bonds Have Fallen to an Attractive Level? - After the adjustment, the overall yield of science - innovation bonds increased, and the inversion between the average valuation of short - term component bonds and the 1 - year AAA certificate of deposit yield improved significantly. However, the yields of 1 - year - below and 1 - 2 - year science - innovation bond index component bonds of AAA grade were still 1 - 2 BP lower than the 1 - year AAA certificate of deposit yield [39]. - The relative spread between exchange - traded and inter - bank science - innovation bonds of the same issuer showed differentiation. Index component science - innovation bonds with a widening relative spread have certain value, and investors can participate at the current adjusted points [44]. - For allocation portfolios, some exchange - traded science - innovation bonds with a remaining term of 4 - 5 years are worth considering due to the relatively large increase in valuation compared to their inter - bank counterparts and the attractive static coupon income [46]. - For trading portfolios, it is more advisable to focus on 1 - 2 - year index component science - innovation bonds that have adjusted significantly, have a large outstanding scale, and a valuation higher than 1.67% [49].

| 基金名称 | 招商瑞安 1年持有期混合型证券投资基金 | | --- | --- | | 基金间称 | 招商瑞安 1年持有期混合 | | 基金主代码 | 011190 | | 基金管理人名称 | 招商基金管理有限公司 | | 公告依据 | 《基金管理公司投资管理人员管理指导意 见》《公开募集证券投资基金信息披露管理办 | | | 法》《证券期货经营机构投资管理人员注册登 | | | 记规则》 | | 基金经理变更类型 | 增聘基金经理,解聘基金经理 | | 新任基金经理姓名 | 林謝 | | 共同管理本基金的其他基金经理姓名 | 杜亮 | | 离任基金经理姓名 | 余芽芳 | | 基金名称 | 招商瑞泰1年持有期混合型证券投资基金 | | --- | --- | | 基金简称 | 招商瑞泰 1年持有期混合 | | 基金主代码 | 012965 | | 基金管理人名称 | 招商基金管理有限公司 | | 公告依据 | 《基金管理公司投资管理人员管理指导意 见》《公开募集证券投资基金信息披露管理办 法》《证券期货经营机构投资管理人员注册登 | | | 记规则》 | | 非令经理变更类型 | 增聘基金经理,解聘基 ...

Market Review - The equity market indices experienced significant gains last week, with the Sci-Tech 50 index leading at an increase of 4.63% [5][6] - The bond market saw both short and long-term interest rates rise, with the 10-year government bond yield increasing by 6.72 basis points to 1.732% [8][10] - The majority of the 31 sectors in the Shenwan index reported gains, particularly in the cyclical sectors such as construction materials (up 8.20%) and coal (up 7.98%) [5][6] Equity Product Allocation Strategy - Event-driven strategies include focusing on funds related to the "Promoting Agricultural Product Consumption Implementation Plan" and the "2025 World Artificial Intelligence Conference" [12][13] - The asset allocation strategy suggests a balanced core with a barbell approach, emphasizing dividend and technology sectors [16][17] - Recommended funds include those with a focus on dividend value, balanced styles, and technology growth [16][17] Stable Product Allocation Strategy - The central bank's net injection of 129.5 billion yuan indicates a shift from a tight to a loose monetary stance [18] - The July LPR remained unchanged at 3.0% for the one-year rate and 3.5% for the five-year rate, aligning with market expectations [18][19] - Focus on short-term bond funds while being cautious of high valuations in convertible bonds [19][23] Key Focus Products - Recommended funds include Nord Short Bond A and Huazheng Pure Bond A, with specific attention to their bond and stock allocations [24]

Group 1 - The core point of the news is the approval of the fundraising for the Invesco Great Wall Anheng Gain Three-Month Holding Period Mixed Fund of Funds (FOF) by the China Securities Regulatory Commission (CSRC) [1] - The fund is classified as a mixed fund of funds and is managed by Invesco Great Wall Fund Management Co., Ltd. with Ningbo Bank as the custodian [1][9] - The public offering period for the fund is set from August 11, 2025, to August 29, 2025, with a maximum fundraising period of three months [1][12] Group 2 - Investors must open a fund account with the company to purchase the fund, and the minimum initial subscription amount is set at 1 yuan [2][9] - There is no upper limit on the maximum subscription amount for individual accounts during the fundraising period, but if a single investor's total subscription reaches or exceeds 50% of the total fund shares, the management may impose restrictions [3][23] - The fund has a minimum holding period of three months, during which investors cannot redeem or convert their shares [5][6] Group 3 - The fund aims to raise at least 200 million yuan and a total of at least 200 investors for the contract to take effect [12][30] - The fund's net value may fluctuate due to market volatility, and investors are advised to read the fund's prospectus and contract carefully [6][31] - The fund's sales will be conducted through direct sales centers and other sales institutions, with specific procedures outlined for account opening and subscription [10][24]

Core Viewpoint - Multiple funds have issued premium risk alerts, particularly QDII funds, indicating a significant increase in premium risk notifications since July, with a notable impact on investor decisions [1][3]. Group 1: Premium Risk Alerts - As of July 28, five funds issued premium risk alerts, contributing to over 70 notifications in July alone, with six out of ten being QDII funds [1][3]. - The Guotai S&P 500 ETF (QDII) and the Invesco Great Wall S&P Consumer ETF (QDII) have issued 21 premium risk alerts since July [1][3]. - The premium rates for the aforementioned funds reached 7.95% and 20.64% respectively as of July 28 [3]. Group 2: Market Performance and Fund Returns - The three major U.S. stock indices have shown year-to-date gains of 5.54%, 9.31%, and 8.62% respectively [4]. - The performance of QDII funds has been notable, with the Huatai-PineBridge Hong Kong Advantage Selected Mixed Fund (QDII) achieving a year-to-date return of 135.58%, ranking first among all market products [4]. - Other QDII funds in the healthcare and innovation sectors have also reported year-to-date returns exceeding 80% [4]. Group 3: Market Valuation and Investment Considerations - The forward P/E ratio of the S&P 500 index has reached 23.3, indicating limited valuation attractiveness [5]. - Market analysts suggest that while the U.S. market may continue to trend upward, uncertainties remain, and significant investments should be approached with caution due to high premium risks [5]. - Investors are advised to monitor premium rates closely, with alerts for rates exceeding 5% and heightened caution for rates above 10% due to potential liquidity risks [5].

Group 1 - The company has signed sales agreements with multiple securities firms to expand the distribution of its funds starting from July 28, 2025 [1][4][9][17] - New sales institutions include Wanlian Securities, Shenwan Hongyuan Securities, Shenwan Hongyuan West Securities, and Dongfang Securities [1][4][9][11][17] - The specific sales arrangements will be determined by the respective sales institutions, and investors are advised to pay attention to their announcements [1][4][9][17] Group 2 - The company emphasizes that the investment processes, including regular investment and conversion services, will depend on the sales institutions' regulations [5][6][12] - Investors can inquire about details through the customer service numbers and websites of the company and the respective sales institutions [2][13]

首批21家机构入选网下专业机构投资者 "白名单" 智通财经7月25日电，中证协发布2024年网下专业机构投资者 "白名单"，共有首批21家网下专业机构投 资者纳入"白名单"。包括博时基金、大成基金、富国基金、广发基金、国泰基金、华安基金、华泰资 管、汇添富基金、交银施罗德基金、景顺长城基金、南方基金、平安资管、睿远基金、东方证券资管、 泰康资管、银华基金、招商基金、中金公司、人寿养老保险、中欧基金、中信证券。中证协将对纳 入"白名单"网下投资者采取激励措施，例如开通网下投资者注册绿色通道，供相关监管部门、自律组织 等在分类监管、自律管理等工作中参考使用。（智通财经记者 林坚） | | 2024年网下专业机构投资者"白名单" | | --- | --- | | 序号 | 网下投资者名称 | | 1 | 博时喜美最插掉限公司 | | 2 | 大成基金管理有限公司 | | 3 | 富国墓会管理有限公司 | | 4 | 广发基金管理有限公司 | | 5 | 国泰基金管理有限公司 | | 6 | 华安基金管理有限公司 | | 7 | 华泰资产管理有限公司 | | 8 | 汇添富基金管理股份有限公司 | | 9 | 交银 ...

| TRE | 图片图图图 | | | --- | --- | --- | | | | 日の日本人が、無理の出版社の記者が出来ない | | | | 177. CEALOW | | | | 图层大 (送信) | | | 中国农业银行配资有限公司 | 1012 (010-365109219) | | | | 10 10 85109219 | | | | 案后面接面试 95599 | | | | minory a viet vice a com | | 某金代码 | 高位名称 | 10000 | 是图书 | 是否参加销售根和印刷(含定假定 MOTH FLANT & BECK (B) CLE TSC | | --- | --- | --- | --- | --- | | alart3.5014 | 1994年四面体制造型设备 20 | 1171 10 | 开元 | 版 | | 013505 | FOR COLLECTION | -1-21 10 | 开通 | 不法用 | | 15227 | 调医校周空探 | 销售模型或具 | | --- | --- | --- | | | | 在第一次公司地址:本名的成绩人感到了中共 ...

Group 1 - The fund being launched is the Invesco Great Wall CSI Chip Industry Exchange-Traded Fund (ETF) Initiated Link Fund, approved by the China Securities Regulatory Commission (CSRC) [1] - The fund is classified as an equity-type initiated securities investment fund and an ETF link fund [9][10] - The fund's initial share value is set at 1.00 RMB [10] Group 2 - The subscription period for the fund is from July 28, 2025, to July 30, 2025 [12] - The minimum initial subscription amount is 1 RMB, with no limit on additional subscriptions [2][24] - Investors can subscribe through the company's direct sales center or other sales institutions [17] Group 3 - The fund will invest at least 90% of its net asset value in the underlying ETF, which focuses on the chip industry [7] - The fund's net asset value may fluctuate due to market volatility [7] - The fund's management company is Invesco Great Wall Fund Management Co., Ltd., and the custodian is Guotou Securities Co., Ltd. [1][38] Group 4 - The fund's subscription fee for Class A shares will be charged at a decreasing rate based on the subscription amount, while Class C shares will not incur a subscription fee [19][20] - The fund's subscription process requires investors to open a fund account and submit necessary documentation [26][27] - The fund's management has the right to adjust the subscription arrangements based on various factors [6][14]